• Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
Whistleblower Network News
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
No Result
View All Result
Home False Claims-Qui Tam

Exposing the Pharmaceuticals Industry: Insights From A Novartis Whistleblower

Ana PopovichbyAna Popovich
July 28, 2020
in False Claims-Qui Tam, News
Reading Time: 3 mins read
Pharmaceutical Company Pays $39 Million to Settle False Claims Act Case
Share on TwitterShare on FacebookShare on LinkedInEmail

Oswald Bilotta provided the public with an insider’s look into the pharmaceutical industry in an exclusive interview with NBC News published on July 7.

A former sales representative for Novartis Pharmaceuticals, Bilotta filed a whistleblower lawsuit under the False Claims Act (FCA) in 2011. He alleged that Novartis provided special treatment to physicians and spent lavishly to treat them—in exchange, the physicians were to prescribe their patients Novartis drugs. Expensive dinners and drinks, fancy catered events, and pricey seats at sporting events are just some of the gifts that Bilotta claimed Novartis gave participating physicians.

The U.S. government joined the case in 2013. It alleged that between 2002 and 2011, Novartis hosted speaker programs that claimed to have an educational basis but, in reality, functioned as a space in which the company could bribe physicians. At these events, usually held at expensive restaurants, Novartis would pay physicians lofty speaker’s fees. Sometimes, the programs would not even occur. However, Novartis would still pay the physician speaker as a bribe to prescribe Novartis drugs, according to the allegations of the Department of Justice (DOJ).

Support Whistleblower Network News

In his interview with NBC News, Bilotta said that when he joined Novartis in 1999, “he felt he had made it” because of the positions’ competitiveness. But shortly after he began working there, he observed that “keeping high-prescribing doctors happy was an intense focus.” Early on in his sales representative position, Bilotta encountered a doctor who expected to receive a $100 restaurant gift certificate in exchange for prescribing a Novartis drug to 10 patients. Sales representatives themselves were given “hundreds of dollars in American Express gift checks to present to doctors.”

During his tenure with Novartis, the misconduct Bilotta witnessed only worsened. “We went from a strictly product focus to one that is more about incentivizing,” he said. NBC reports that “in the mid-2000s, Novartis began ramping up its doctor speaker programs”—programs that, as the public now knows, were mostly shams focused on paying bribes for doctors and promoting Novartis drugs.

Even though Novartis “created a compliance department in 1999,” the fraudulent activity was not investigated; instead, the company actively suppressed it. The settlement stated that “compliance training materials discouraged sending emails about the activities.” In presentations, the chief compliance officer urged employees to discuss matters over the phone rather than in writing.

When Bilotta went to a superior in 2010 and said he had “evidence of fraud,” he was threatened and began working with law enforcement in 2011 before filing the FCA lawsuit. His work included wearing a wire at the behest of law enforcement to record interactions with doctors during which cash bribes were taken. Bilotta’s name was later leaked, which led to his receiving “death threats and online taunts.”

Bilotta retired from Novartis in 2013 and said that now, “he wants to work to change health care practices and laws that harm patients and taxpayers.”

“The whole system needed to be blown up and pieced together in a fair way — fair for taxpayers and good for patients,” Bilotta said of the pharmaceutical industry.

Read more about this False Claims Act case against Novartis on Whistleblower Network News.

Previous Post

Whistleblower Film Festival to Feature Unrepresented, a Documentary Film about Political Corruption in America

Next Post

Whistleblower Film Festival Review: In Nicaragua, They Name me Chepito

Ana Popovich

Ana Popovich

Ana Popovich is a contributing editor with Whistleblower Network News, where she writes about breaking whistleblower news, healthcare fraud whistleblowers, and Covid-19 fraud whistleblowers. Ana has a B.A. in English from Georgetown University. While at Georgetown, she was the marketing chair of an affinity group and wrote content for the McDonough School of Business’ Business for Impact program. In 2018, Popovich was a public interest legal intern at the whistleblower law firm Kohn, Kohn and Colapinto. 

Next Post
Whistleblower Film Festival Review: In Nicaragua, They Name me Chepito

Whistleblower Film Festival Review: In Nicaragua, They Name me Chepito

Please login to join discussion

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

Change the Culture, Make National Whistleblower Day Permanent

Tell President Biden to “Finish the Job” for Whistleblowers

Whistleblower Advocates See Parallels to Enron in Silicon Valley Bank Collapse

Whistleblower Jóhannes Stefánsson Plans to Testify at Fishrot Trial in Namibia

WNN Exclusive Interview with Social Security Whistleblowers Sarah Carver and Jennifer Griffith — Part 1

Whistleblower Raised Concerns of Rodents, Spiders in Kitchen of Childcare Facility, Then Fired; OSHA Rules They Were Retaliated Against

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • The Whistleblowers Handbook
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article

Copyright © 2021, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook
  • National Whistleblower Day ’23

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN

Add New Playlist

Go to mobile version